• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
United States Court of Appeals Argued March 1, 2007 No. 04-5350
United States Court of Appeals Argued March 1, 2007 No. 04-5350

... application for human testing has been approved, see id. § 312.20, several phases of clinical testing begin. The Alliance’s amended complaint alleges that this testing process is an extremely lengthy one, requiring nearly seven years for the average experimental drug.1 Am. Compl. ¶ 15. Clinical test ...
Diphenhydramine Hydrochloride Injection, USPRx only
Diphenhydramine Hydrochloride Injection, USPRx only

... As in adults, antihistamines may diminish mental alertness in pediatric patients. In the young pediatric patient, particularly, they may produce excitation. Us e in the Elderly (approximately 60 years or older) Antihistamines are more likely to cause dizziness, sedation and hypotension in elderly pa ...
High Cost Drugs policy - Province of British Columbia
High Cost Drugs policy - Province of British Columbia

... When a pharmacy provider mistakenly charges product or dispensing fee costs directly to an individual for a claim to which the Full Payment policy applies, the pharmacy provider must refund those charges to the individual. ...
Phytosomes - Journal of Chemical and Pharmaceutical Research
Phytosomes - Journal of Chemical and Pharmaceutical Research

... In order to amalgamate different water-soluble phytoconstituents into phospholipids to yield molecular complexes that are compatible with lipid, a technology had developed which also fruitfully improve their absorption and bioavailability. These molecular complexes are acknowledged as Phytosomes or ...
FDA Supplement - Oregon State University Research Office
FDA Supplement - Oregon State University Research Office

... In some cases dietary supplements or substances generally recognized as safe (GRAS) are considered to be drugs when they are used to diagnose, cure, mitigate, treat, or prevent disease. Under FDA regulations, research that involves use of a drug other than the use of a marketed drug in the course of ...
Sabiduría  Spring 2015 Table of Contents
Sabiduría Spring 2015 Table of Contents

... populations and longer durations of drug administration to patient population sets. The side effects may range from trivial inconveniences to life threatening reactions or significant health complications such as new comorbidities. There are however methods in place for healthcare professionals to t ...
Paul G. King Consulting
Paul G. King Consulting

... chronic toxicity, or non-reversible tissue damage were found in a particular fraction, the firm should identifi impurities down to the “0.05 percent level (at the wavelength where each impurity has the maximum relative response to the active) for APIs that are intended to treat acute medical conditi ...
P4 - ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE)  PRECEPTOR MANUAL
P4 - ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) PRECEPTOR MANUAL

... professional. Elective experiences give students the opportunity to gain insight in areas such as academia, research, drug information, compounding, and professional association management among others. Students may also take additional clinical selective rotations, community, or hospital rotations ...
John Wang
John Wang

Re: Draft Guidance "Pharmacy Compounding of Human
Re: Draft Guidance "Pharmacy Compounding of Human

... product, then it must appear on a “list developed by the Secretary through regulations….” in order to be used by a compounding pharmacy to fill a prescription. Paragraph 3 of the of FDA’s Draft Guidance confirms that bulk substances must comply with the standards of an applicable USP or NF monograph ...
Phenytoin Sodium 50 mg Film-coated Tablets
Phenytoin Sodium 50 mg Film-coated Tablets

ESTIMATION OF CLOFAZIMINE IN CAPSULE DOSAGE FORM BY USING UV-VIS...
ESTIMATION OF CLOFAZIMINE IN CAPSULE DOSAGE FORM BY USING UV-VIS...

... Method: A simple, accurate, sensitive and precise Ultraviolet specrophotometric method has been developed for the determination of clofazimine in capsule dosage form. The solutions of standard and sample were prepared in benzene. Results: In the UV specrophotometric method, the quantitative determin ...
USP`s Role in Patient Safety Goals: Objectives
USP`s Role in Patient Safety Goals: Objectives

... Health Literacy and Prescription Container Labeling The Health Literacy and Prescription Container Labeling Advisory Panel of the SMU EC is working on recommendations for the development of standards regarding simplifying language; using explicit text to describe dosage/intervals, including purpose ...
Public Assessment Report Scientific discussion Oxcarbazepine CF
Public Assessment Report Scientific discussion Oxcarbazepine CF

... of dosage units. The release and shelf-life requirements/limits are identical with the exception of the limits for water and total impurities, which can be accepted. The analytical methods have been adequately described and validated. Batch analyses data has been provided for two pilot-scale batches ...
Herbal Plants Used as Diuretics: A comprehensive Review
Herbal Plants Used as Diuretics: A comprehensive Review

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES AND
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES AND

... INTRODUCTION ...
Effects of Solubility and Dissolution Characteristics on Oral
Effects of Solubility and Dissolution Characteristics on Oral

... Approximately 20% of an oral administered dose of alitretinoin is absorbed with systemic exposure variability reducing from 70 % to 40% when taken with food. Alitretinoin is currently approved in several European Union ...
DARIYA GORDIYCHUR, AHMED RALIAT
DARIYA GORDIYCHUR, AHMED RALIAT

... contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost. Years of studies shows acetylcysteine’s ability of treating and preventing the cause of chronic generalised periondontitis due to its antioxidant, antiradical and ...
Standard 1: The pharmacy manager will ensure that nonprescription
Standard 1: The pharmacy manager will ensure that nonprescription

... In February of 2004, the Importation and Compounding of Animal Drugs Task Force met to discuss several issues related to the use of compounded products in Canada. It was decided that guidelines needed to be developed in collaboration with provincial pharmacy licensing bodies to describe when it is a ...
BASS & ULLMAN, E G.
BASS & ULLMAN, E G.

... The OTC drugs generally contain available. lesser amounts of the active agent than prescription forms and are effective for a shorter period. They may be useful, however, asthma for mild treatment temporary as Ready availability in drugstores attacks. makes OTC products potentially helpful as a “sto ...
PHARMACEUTICAL PACKAGING, COMPONENT AND EVALUATION
PHARMACEUTICAL PACKAGING, COMPONENT AND EVALUATION

... In solid preparations to prevent the collision of individual units or to absorb moisture etc. ...
document - Castle Point and Rochford CCG
document - Castle Point and Rochford CCG

Basic Principles of GMP
Basic Principles of GMP

... Impetus for formation of US Food & Drugs Administration Federal Food, Drug and Cosmetic Act (1938) required toxicological testing for all new drugs ...
PSA Questions Adverse Drug Reactions Template
PSA Questions Adverse Drug Reactions Template

... Type C. This question type will require the candidate to consider a presentation where there are potential interactions between medicines currently being prescribed to a patient and identify those that might be clinically important. Examples might include interactions such as warfarin–statins, NSAID ...
Pharmaceuticals: Focussing on Appropriate Utilization
Pharmaceuticals: Focussing on Appropriate Utilization

... However, indicators of both utilization and appropriateness, which are antecedents of effectiveness, are possible to measure using Manitoba Health's databases. This project reports on the Manitoba Centre for Health Policy's (MCHP) efforts to develop methods to establish comparative benchmarks for ph ...
< 1 ... 26 27 28 29 30 31 32 33 34 ... 130 >

Pharmaceutical marketing

Pharmaceutical marketing, sometimes called medico-marketing or pharma marketing in some countries, is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs.Many countries have measures in place to limit advertising by pharmaceutical companies.Pharmaceutical company spending on marketing far exceeds that of its research budget. In Canada, $1.7 billion was spent in 2004 to market drugs to physicians; in the United States, $21 billion was spent in 2002. In 2005, money spent on pharmaceutical marketing in the United States was estimated at $29.9 billion with one estimate as high as $57 billion. When the U.S. numbers are broken down, 56% was free samples, 25% was pharmaceutical sales representative ""detailing"" (promoting drugs directly to) physicians, 12.5% was direct to user advertising, 4% on detailing to hospitals, and 2% on journal ads. There is some evidence that marketing practices can negatively affect both patients and the health care profession.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report